Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Stroke Meeting 2020

About Conference

We are glad to announce annual meeting “11th International Conference on Stroke, Neurology and Cerebrovascular Diseases" to be held at Paris, France on October 19-20, 2020. Stroke Meeting 2020 is working under the theme: “Vision towards Stroke, Neurological Disorders and Recovery”.

Neuroscience defines the systematic study of the mechanics of the central nervous system such as its structure, function, physiology, and genetics including by what means this can be related to understand diseases of the nervous system where as ‘Neurology’ is the branch of medicine that is concerned with diseases and disorders of the nervous system ranging from Alzheimer's disease, epilepsy, dementia & stroke, migraine respectively including neuroinfectious and brain tumors. Neurology includes diagnosing and treating conditions of the central, peripheral and autonomic nervous systems.

The field neurology includes a broad range of subspecialties few of them are child neurology, clinical neurophysiology, endovascular surgical neuroradiology, hospice & palliative medicine, neuromuscular medicine, sleep medicine, pain medicine, vascular neurology, autonomic disorders, behavioral neurology & neuropsychiatry, geriatric neurology, neural repair & rehabilitation medicine, neuroimaging, neuro-oncology, psychosomatic medicine, neurosurgery.

Market Analysis

The scope of this report is broad and includes therapeutics used in the treatment of neurological disorders. The market analysis of neurology represents the largest and untapped market in medicine sector. This estimated market analysis is based on probability of approval and sales of products in late stage development, demographic trends and marketing of product. Emerging markets once again helps to boost revenues. CNS therapeutics covers approximately 15% of total pharmaceutical sales, almost $30 billion worldwide. The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024. International neurology market consists of various therapeutics used for the treatment of different neurological disorders, the novel pipeline, patent expiry of blockbuster drug and new drug approval have affected the neurology market and it is estimated to grow during the forecast period. The biopharmaceutical companies are financing significantly in the development of innovative therapeutics for the treatment of neurological disorders. Government organizations are funding research & development related to neurology research. These factors are influencing the neurology market positively coupled with the growing prevalence of neurological disorders. The improved government funding in neurology research and an ever-growing demand for research centred on drug discovery for enhancement of novel therapies in neurological disorders are driving the growth of neurology market. The global market for psychotic disease is predicted to grow at a slow rate during the forecast period.

The slow progress is attributed primarily to the loss of patent exclusivity of branded drugs and the emergence of generic drugs. Manufacturers of branded drugs are expected to experience a decline in sales revenue due to the penetration of low-cost generic drugs in the market, which is likely to influence the growth of the market for antipsychotic drugs. New approaches for the treatment of neurology related indications were pursued by pharmaceutical companies. This new drug with a novel method of action or improved delivery system will present a powerful new option to currently prescribed neurology medicines. The global neurology market is growing due to a rise in the aging population, increased awareness regarding mental & neurological illness, increasing health insurance reforms and constant research & development in neurology by pharmaceutical companies. These factors along with technological advances such as 3D printed drugs, biomarkers, wearable technologies and mobile applications used to monitor and treat patients diagnosed with neurological disorders are expected to drive the neurology drugs industry. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on drug manufacturers' total revenues. Projected and forecasted revenue values are in constant US dollars, unadjusted for inflation. European neurological disorders have been depicted in the below graph. 

Past Conference Report

The 7th Global Experts Meeting on Neuropharmacology, hosted by the Conference Series was held during July 31- August 02, 2017 at Hilton Garden Inn Milan North, Milan, Italy  Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success.

We expresses our gratitude to the conference Moderators, namely Dr. Jong Eun Lee, Dr. Mariya Hristova and Dr. Maha Nada for taking up the responsibility to co-ordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Hari Shanker Sharma, Uppsala University, Sweden

Stephen D Skaper, University of Padua, Italy

David Truswell, Somefreshthinking Consultancy, UK

Michael V Ugrumov, Institute of Developmental Biology RAS, Russia

Ni Hong, Soochow University, China

M Cohen-Armon, Tel-Aviv University, Israel

Istvan Berczi, University of Manitoba, Canada

We are grateful to our Spekaers of Special session. The list comprises:

Harish C Pant, National Institutes of Health, USA

Yacov Rofé, Bar-Ilan University, Israel

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Neuro Immune Pharmacology
Molecular Neuropharmacology
Neurochemical Transmission
Behavioral Neuropharmacology
Alzheimer’s Disease and Dementia
Parkinson’s Disease
Future Aspects of Neuropharmacology
Clinical Neuropharmacology
Chemical Neurotransmitters
Case Study Reports
Entrepreneurs Investment Meet

We offer our   heartfelt appreciation to organizations such as Bentham Science and our esteemed supporters SelectScience Trade Show Alerts  Medgenera Crowd Reviews PBR Clinical Biometrics Bio-Equip Nanobay Pharma Focus Asia ManuscriptEdit Times International eindiabusiness  and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. We also took the privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Neuropharmacology 2017, We are proud to announce the "11th International Conference on Stroke, Neurology and Cerebrovascular Diseases" to be held during October 19-20, 2020 in Paris, France.

To Collaborate Scientific Professionals around the World

Conference Date October 19-20, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Neurological Disorders Journal of Cardiovascular Diseases & Diagnosis International Journal of Neurorehabilitation

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


  • Alzheimer’s Disease
  • Angina Pectoris
  • Antihypertensive Drugs
  • Anxiety
  • Arrhythmia
  • Atherosclerosis
  • Autism In Adults
  • Autism In Children
  • Autoregulation
  • Blood Cells
  • Blood Clot
  • Blood Vessels
  • Brain
  • Brain Death
  • Brain Hemorrhage
  • Brain Mapping
  • Brain Stroke
  • Brain Tumors
  • Cancer Cells
  • Cardiac Arrest And Recovery
  • Cardiac Stroke
  • Cardiologist
  • Cardiovascular And Stroke Nursing
  • Carotid Stenosis
  • Cerebrospinal Fluid
  • Cerebrovascular Diseases
  • Chest Pain
  • Chronic Stress
  • Circulatory System
  • Clinical Trials And Case Reports
  • CNS Disorder
  • CNS Metastasis 
  • Congenital Heart Disease
  • Dementia
  • Demyelination
  • Depression
  • Dysphagia
  • Electrocardiogram (ECG)
  • Electroencephalogram (EEG)
  • Embolism
  • Emergency Medicine Doctor
  • Epilepsy/Seizures
  • Episodic Acute Stress
  • Genetic Disorder
  • Head Injuries
  • Headache
  • Heart
  • Heart Diseases
  • Heart Failure
  • Hemorrhagic Stroke
  • High Blood Pressure
  • Hypertension
  • Hypoesthesia
  • Infantile Spasms
  • Ischemic Stroke
  • Magnetic Resonance Imaging (MRI)
  • Meningitis
  • Mental Health
  • Migraine
  • Multiple Sclerosis (MS)
  • Myelin Sheath
  • Myelopathy
  • Nerves
  • Nervous System
  • Neuro Pharmacology
  • Neuro-oncology
  • Neurodegenerative Diseases
  • Neuroimaging
  • Neurological And Cognitive Deficits
  • Neurological Disorders
  • Neurologist
  • Neurology
  • Neuroma 
  • Neurons
  • Neuroplasticity
  • Neuroscience
  • Neurosurgeon
  • Neurosurgery
  • Obesity
  • Occupational Therapy
  • Paralysis
  • Parkinson's Disease
  • Peripheral Artery Disease
  • Physical Therapy
  • Primary Care Provider
  • Psychological Counselling
  • Psychological Disorders
  • Psychologist
  • Psychospiritual Stress
  • Schizencephaly
  • Speech Therapy
  • Stroke
  • Stroke Rehabilitation
  • Stroke Rehabilitation And Recovery
  • Transient Ischemic Attack
  • Vascular Malformations
  • Vascular Surgeon
  • Wallenberg Syndrome
  • Xanthochromia